Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd.
| Azurity Pharmaceuticals, Inc. |
| Alkem Laboratories Ltd. |
| 1:2020cv01094 |
| August 20, 2020 |
| US District Court for the District of Delaware |
| Leonard P Stark |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 1 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 4, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 10
WAIVER OF SERVICE returned executed by Azurity Pharmaceuticals, Inc.: For Alkem Laboratories Ltd. waiver sent on 10/1/2020, answer due 11/30/2020. (Dellinger, Megan)
|
|
Filing 9
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,688,046 . (Dellinger, Megan)
|
|
Filing 8
First AMENDED COMPLAINT against Alkem Laboratories Ltd.- filed by Azurity Pharmaceuticals, Inc.. (Attachments: #1 Exhibit A-B)(Dellinger, Megan)
|
|
SO ORDERED, re #7 MOTION for Pro Hac Vice Appearance of Attorney Tung-On Kong, Wendy L. Devine, and James P.H. Stephens filed by Azurity Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 9/16/20. (ntl)
|
|
Filing 7
MOTION for Pro Hac Vice Appearance of Attorney Tung-On Kong, Wendy L. Devine, and James P.H. Stephens - filed by Azurity Pharmaceuticals, Inc.. (Dellinger, Megan)
|
|
Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb)
|
|
Filing 6
Summonses Issued (please complete the top portion of the form and print out for use/service). (mal)
|
|
Filing 5
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent CutisPharma Intermediate Holdings, Inc. for Azurity Pharmaceuticals, Inc. filed by Azurity Pharmaceuticals, Inc.. (mal)
|
|
Filing 4
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,493,028 B2. (mal)
|
|
Filing 3
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/8/2020. Date of Expiration of Patent: 3/13/2035.Thirty Month Stay Deadline: 1/8/2023. (mal)
|
|
Filing 2
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal)
|
|
Filing 1
COMPLAINT FOR PATENT INFRINGEMENT - filed against Alkem Laboratories Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3143889.) - filed by Azurity Pharmaceuticals, Inc.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(mal)
|
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
| Search for this case: Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd. | |
|---|---|
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Web | [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ] |
| Defendant: Alkem Laboratories Ltd. | |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
| Plaintiff: Azurity Pharmaceuticals, Inc. | |
| Represented By: | Jack B. Blumenfeld |
| Represented By: | Megan Elizabeth Dellinger |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
